Detalhe da pesquisa
1.
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
Lancet
; 401(10392): 1941-1950, 2023 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105210
2.
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Acta Haematol
; 146(3): 230-239, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603565
3.
Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial.
Clin Infect Dis
; 75(5): 777-785, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986227
4.
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study.
Am J Hematol
; 96(1): 80-88, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108024
5.
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Ann Hematol
; 99(8): 1855-1862, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564196
6.
Iatrogenic cutaneous graft versus host disease.
Dermatol Online J
; 26(11)2020 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342180
7.
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(9): 1798-1802, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31129355
8.
The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm.
Hematol Oncol
; 37(4): 487-489, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465531
9.
Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Am J Hematol
; 93(3): 416-423, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29226497
10.
[Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Deuxième allogreffe (mise à jour). Recommandations de la Société francophone de greffe de moelle osseuse et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 111(2S): S29-S39, 2024 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-37045732
11.
Platelet transfusions in haploidentical haematopoietic stem cell allograft candidates: Protecting HLA-A and HLA-B antigens through eplet analysis.
HLA
; 103(3): e15438, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516935
12.
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
J Hematol Oncol
; 17(1): 2, 2024 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185663
13.
Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease.
Br J Haematol
; 181(5): 687-689, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444730
14.
5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy.
Am J Hematol
; 88(7): 601-5, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23619977
15.
Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease.
Leuk Res
; 125: 107005, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580876
16.
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.
Bone Marrow Transplant
; 58(5): 534-543, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774430
17.
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial.
EClinicalMedicine
; 62: 102111, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654670
18.
Beneficial outcomes and epidemiologics of atypical electrophoretic profiles arising after allogeneic hematopoietic stem cell transplantation for myeloid malignancies.
Curr Res Transl Med
; 70(1): 103322, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801813
19.
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.
Bone Marrow Transplant
; 57(9): 1421-1427, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752739
20.
A one-step assay for sorted CD3+ cell purity and chimerism after hematopoietic stem cell transplantation.
HLA
; 97(3): 183-187, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314632